The Role of Ahr in Anticancer Drug Resistance in Breast Cancer

Breast cancer has been a significant health problem in terms of both morbidity and mortality and has been the second leading cause of cancer deaths worldwide. Exploring and understanding the cellular and molecular mechanisms of BC tumorigenesis and progression, as well as resistance to chemotherapeu...

Full description

Saved in:
Bibliographic Details
Published inJournal of bioanalysis & biomedicine Vol. 7; no. 3; p. 87
Main Author Lili Cui, Conghui Zhu
Format Journal Article
LanguageEnglish
Published OMICS Publishing Group 01.01.2015
Subjects
Life Sciences
Aryl hydrocarbon receptor
Aryl hydrocarbon receptor Breast cancer Drug resistance
Breast cancer
Drug resistance
Online AccessGet full text

Cover

More Information
Summary:Breast cancer has been a significant health problem in terms of both morbidity and mortality and has been the second leading cause of cancer deaths worldwide. Exploring and understanding the cellular and molecular mechanisms of BC tumorigenesis and progression, as well as resistance to chemotherapeutic drugs involved will be critically important for advancing the overall efficacy of BC therapy. The increasing data demonstrates high levels of constitutively active AhR in mammary tumors, suggesting there is a putative role for the AhR in mammary gland tumorigenesis, while target the AhR for new drug discovery and development has been payed more attention in recent years. This present study aims to provide a relative detailed understanding and progression on the integrated role of AhR in BC tumorigenesis and in BC resistance to chemotherapeutic drugs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1948-593X
1948-593X
DOI:10.4172/1948-593X.1000129